← Open Payments lookup

ADAM HARTHEIMER: Open Payments

NPI 1235799420 · CHEVY CHASE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$493 in 21 payments from 8 companies in 2025. Trend: 2023 $0 · 2024 $427 · 2025 $493

Food & beverage: $493
CompanyPaymentsAmount
Regeneron Healthcare Solutions, Inc.8$189
GENZYME CORPORATION6$153
Optinose US, Inc.2$46
HARMONY BIOSCIENCES LLC1$29
GlaxoSmithKline, LLC.1$23
Phathom Pharmaceuticals, Inc.1$19
Amgen Inc.1$17
AstraZeneca Pharmaceuticals LP1$16

Products named: DUPIXENT, Xhance, TEZSPIRE, WAKIX, NUCALA, VOQUEZNA.

Industry payments across MD — which companies pay providers there.